Skip to main content
Tags: coronavirus | treatment | human trial | remdesivir

US Testing Possible Coronavirus Treatment on Humans

a man is shown wearing a facial mask
(Oscar Del Pozo/Getty Images)

By    |   Wednesday, 26 February 2020 02:40 PM EST

Researchers in the United States have begun human trials of a drug that could treat the coronavirus that has infected over 80,000 people and killed over 2,700 worldwide, CNN reports.

The National Institute of Health announced Tuesday that the University of Nebraska Medical Center has started a clinical trial to test the safety and effectiveness of remdesivir, an antiviral drug, in adults who have been diagnosed with the coronavirus, known by the official name COVID-19. 

“We urgently need a safe and effective treatment for COVID-19. Although remdesivir has been administered to some patients with COVID-19, we do not have solid data to indicate it can improve clinical outcomes,” said Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, which is the trial’s regulatory sponsor. Fauci also is a member of the U.S. Coronavirus Task Force. “A randomized, placebo-controlled trial is the gold standard for determining if an experimental treatment can benefit patients.”

Patients who have been hospitalized and show at least moderate symptoms of the virus will be eligible for the trial. A group of 14 American citizens who were evacuated from the cruise ship the Diamond Princess are being treated at the University of Nebraska Medical Center, 12 of whom tested positive for the coronavirus.

“The goal here is to help the people that need it the most,” Dr. Andre Kalil, who is overseeing the study, told ABC News.

Theodore Bunker

Theodore Bunker, a Newsmax writer, has more than a decade covering news, media, and politics.

© 2025 Newsmax. All rights reserved.


Newsfront
Researchers in the United States have  begun human trials of a drug that could treat the coronavirus that has infected over 80,000 people and killed over 2,700 worldwide, CNN reports.
coronavirus, treatment, human trial, remdesivir
236
2020-40-26
Wednesday, 26 February 2020 02:40 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved